Skip to main
ONCT
ONCT logo

Oncternal Therapeutics Inc (ONCT)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ONCT Stock

About Oncternal Therapeutics Inc (ONCT)

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Market cap$1.56M
Today's volume702.15K
Revenue (TTM)$2.16M
Avg. daily volume
EBITDA (TTM)-$35.96M
Open$0.70
Price / earnings ratio-0.05x
Today's range$0.53 - $0.7
Debt / equity2.09x
52 week range$0.53 - $0.53
5 year debt / equity
Beta (LTM)
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio2.39x
Ex-dividend date
Next earningsNov 6, 2024
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for ONCT stock is $1.56M

The current P/E ratio for ONCT stock is -0.05

The 52-week high for ONCT stock is $0.53. The current ONCT stock price $undefined is 100.00% below its 52-week high

The 52-week low for ONCT stock is $0.53. The current ONCT stock price $undefined has increased 100.00% from its 52-week low

No, the ONCT stock does not pay dividends to its shareholders

How to buy ONCT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ONCT stock

    Navigate to the Explore page. Then, type ONCT into the search bar. When you see ONCT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ONCT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Oncternal Therapeutics Inc Stock Earnings

The value each ONCT share was expected to gain vs. the value that each ONCT share actually gained.

ONCT (ONCT) reported Q3 2024 earnings per share (EPS) of -$2.86, beating estimates of -$3.19 by 10.34%. In the same quarter last year, ONCT's earnings per share (EPS) was -$3.40. ONCT is expected to release next earnings on 11/06/2024, with an earnings per share (EPS) estimate of $0.

Buy ONCT Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.